7.21
전일 마감가:
$7.53
열려 있는:
$7.38
하루 거래량:
96,898
Relative Volume:
1.20
시가총액:
$38.58M
수익:
$7.97M
순이익/손실:
$-75.74M
주가수익비율:
-0.2969
EPS:
-24.2853
순현금흐름:
$-85.33M
1주 성능:
-22.64%
1개월 성능:
-28.40%
6개월 성능:
+28.75%
1년 성능:
-23.95%
Aligos Therapeutics Inc Stock (ALGS) Company Profile
명칭
Aligos Therapeutics Inc
전화
(800) 466-6059
주소
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
ALGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ALGS
Aligos Therapeutics Inc
|
7.21 | 52.34M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-18 | 재개 | H.C. Wainwright | Buy |
| 2024-08-19 | 개시 | H.C. Wainwright | Buy |
| 2023-01-06 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-01-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-01-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-09-09 | 개시 | SVB Leerink | Outperform |
| 2021-05-17 | 재개 | Piper Sandler | Overweight |
| 2020-11-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-10 | 개시 | JP Morgan | Overweight |
| 2020-11-10 | 개시 | Jefferies | Buy |
| 2020-11-10 | 개시 | Piper Sandler | Overweight |
모두보기
Aligos Therapeutics Inc 주식(ALGS)의 최신 뉴스
Aligos Therapeutics Inc expected to post a loss of $1.90 a shareEarnings Preview - TradingView
Aligos Therapeutics to Present at Upcoming Investor Conferences - The Manila Times
Aligos Therapeutics (Nasdaq: ALGS) to present at Jefferies Nov 17 and Piper Sandler Dec 3 - Stock Titan
How to forecast Aligos Therapeutics Inc. trends using time series2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
When is the best time to exit Aligos Therapeutics Inc.CPI Data & Weekly Breakout Stock Alerts - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenariosWeekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Why Aligos Therapeutics Inc. stock remains on buy listsWeekly Profit Report & Community Driven Trade Alerts - newser.com
Will Aligos Therapeutics Inc. benefit from macro trendsJuly 2025 Fed Impact & Advanced Technical Signal Analysis - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock safe for risk averse investors2025 Big Picture & Real-Time Price Movement Reports - newser.com
How to build a dashboard for Aligos Therapeutics Inc. stock2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
How buybacks impact Aligos Therapeutics Inc. stock valueWeekly Stock Summary & High Conviction Buy Zone Picks - newser.com
How Aligos Therapeutics Inc. (5WK0) stock stacks up against competitors2025 Market WrapUp & Accurate Buy Signal Alerts - newser.com
Can Aligos Therapeutics Inc. (5WK0) stock double in coming years2025 Price Action Summary & Reliable Price Breakout Alerts - newser.com
Multi factor analysis applied to Aligos Therapeutics Inc.Dollar Strength & Safe Investment Capital Preservation Plans - newser.com
Is Aligos Therapeutics Inc a good long term investmentChart Pattern Recognition & Free Rapid Return Acceleration - earlytimes.in
Is Aligos Therapeutics Inc. stock positioned well for digital economy2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
Aligos Therapeutics, Inc. (ALGS) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Is Aligos Therapeutics Inc. stock supported by strong fundamentalsEarnings Overview Report & Precise Buy Zone Tips - newser.com
Published on: 2025-10-31 04:14:04 - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock a fit for income portfoliosDollar Strength & Weekly Stock Performance Updates - newser.com
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Aligos Therapeutics (Nasdaq: ALGS) to announce financial results Nov 6, 2025 - Stock Titan
Aligos Therapeutics Inc (ALGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):